Mylan, Abbott Bury Hatchet Over Depakote ER
By Anne Urda · June 5, 2008, 12:00 AM EDT
Mylan Pharmaceuticals Inc. and Abbott Laboratories have reached a truce in their long-standing battle over Depakote, as Mylan won permission to sell a knockoff version of Abbott's best-selling extended-release epilepsy drug....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login